Privia Health Group, Inc. Common Stock (PRVA) is a publicly traded Healthcare sector company. As of May 21, 2026, PRVA trades at $23.19 with a market cap of $2.99B and a P/E ratio of 128.57. PRVA moved -0.43% today. Year to date, PRVA is -3.98%; over the trailing twelve months it is -5.46%. Its 52-week range spans $16.47 to $26.51. Analyst consensus is strong buy with an average price target of $31.33. Rallies surfaces PRVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes PRVA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $23.19 |
| Market Cap | $2.99B |
| P/E Ratio | 128.57 |
| EPS | $0.18 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.51 |
| 52-Week Low | $16.47 |
| Volume | 440.41K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.25B |
| Net Income | $27.39M |
| Gross Margin | 0.00% |
15 analysts cover PRVA: 0 strong buy, 14 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $31.33.